US FDA Centers Will Report Directly To Gottlieb: 'Flattened' Structure Will Make Future Political Transitions Easier

Principal Deputy Commissioner Sherman remains top policy guru and will oversee consolidation of functions currently scattered throughout FDA into the Office of Operations.

FDASignBldg21Entrance_1200x675

US FDA's proposed reorganization of the Office of the Commissioner will elevate the agency’s medical product centers to report directly to Commissioner Scott Gottlieb, as part of a “flattening” of the org chart that he announced in an all-FDA email to staff this week.

The six center directors – including the Center for Devices and Radiological Health's Jeff Shuren – will report directly to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Medtech Insight